Although the pharmaceutical industry faces enormous challenges today, these forces are the same ones that will offer opportunities in the near future. This market is cutting through the fog of multiple vulnerabilities armed with a robust scientific base and insight into genetics and genomics.
With rising regulatory requirements and severe tax reform influencing the market’s momentum, pharmaceutical companies must protect their assets. Insurance for pharmaceutical companies is what will ensure that patients’ needs are met continually, and companies stay afloat, in general.
Furthermore, pharmaceutical R&D is expected to grow by 2.4% in the next couple of years. Adequate insurance coverage will help support R&D as well as product sales, extending the life of the company overall.